What is the recommended dose of Clindamycin (Clindamycin) for prophylactic use in a cesarean section (CS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clindamycin Dose for Cesarean Section Prophylaxis

For patients with penicillin/cephalosporin allergy undergoing cesarean section, administer clindamycin 900 mg IV as a single slow infusion 30-60 minutes before skin incision. 1

Standard Dosing Regimen

  • Clindamycin 900 mg IV administered as a slow infusion is the recommended dose for antibiotic prophylaxis in cesarean delivery when patients have documented penicillin or cephalosporin allergies 1, 2

  • The antibiotic should be given 30-60 minutes before skin incision, not after cord clamping, as preoperative administration significantly reduces maternal infectious morbidity 1, 3

Alternative Regimen for Allergic Patients

  • Clindamycin 900 mg IV plus gentamicin 5 mg/kg/day (single dose) may be used as combination therapy for broader coverage in allergic patients 4, 1

  • This combination provides coverage against both aerobic and anaerobic organisms from skin and vaginal flora 4

Duration and Re-dosing

  • Single dose only is required for standard cesarean procedures 1, 2

  • No additional doses are needed if the procedure duration is less than 4 hours 1

  • For prolonged procedures, the evidence does not specifically address clindamycin re-dosing, though general surgical principles suggest re-dosing may be considered if duration exceeds typical half-life considerations 2

Important Clinical Context

Why Not Cefazolin?

  • Cefazolin 2g IV is the first-line agent for cesarean prophylaxis in non-allergic patients, as it provides superior coverage and has the strongest evidence base 1, 5

  • Clindamycin is specifically reserved for patients with documented penicillin/cephalosporin allergies 1, 2

Timing Rationale

  • Administration before skin incision rather than after cord clamping reduces composite maternal infectious morbidity (RR 0.57), endometritis (RR 0.54), and wound infection (RR 0.59) without increasing neonatal sepsis 3

  • The shift to preoperative administration is supported by high-quality evidence and is now standard practice 1, 3

Special Circumstances

  • For women in labor or with ruptured membranes, consider that first-line therapy would include azithromycin added to cefazolin; however, the equivalent regimen for allergic patients would be clindamycin plus gentamicin 1

  • Morbid obesity (BMI >35) may warrant consideration of higher doses, though specific evidence for clindamycin dose adjustment in this population is limited 2

Common Pitfalls to Avoid

  • Do not delay administration until after cord clamping - this outdated practice significantly increases infection risk 1, 3

  • Ensure slow IV infusion of clindamycin to avoid infusion-related reactions 4

  • Verify true allergy status before using second-line agents, as the risk of surgical site infection increases by 50% when second-line antibiotics are used instead of cefazolin 5

References

Guideline

Antibiotic Prophylaxis for Post-Cesarean Section

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotic prophylaxis in obstetric procedures.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cefazolin as Prophylaxis in Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.